El Vall d´Hebron Institute of Oncology (VHIO) busca “Coordinador/a EECC”
Referencia: 2024-001-01
Plazo de finalización de la presentación de candidaturas:
Se trata de una bolsa de empleo para cubrir vacantes que puedan surgir en un futuro.
Descripción de la oferta:
El Vall d'Hebron Instituto de Oncología (VHIO) es un centro de referencia en medicina personalizada en oncología, con un equipo formado por más de 800 profesionales: personal de investigación clínica y preclínica, oncología, enfermería, apoyo a la investigación y apoyo administrativo, que trabajan coordinadamente en la búsqueda de nuevos tratamientos eficaces para los pacientes con cáncer.
Dentro de la Unidad de Ensayos Clínicos, VHIO busca incorporar a un/a Coordinador/a de Ensayos Clínicos.
Entre las principales responsabilidades y funciones a desarrollar, bajo la supervisión y dependencia de la dirección de la unidad, se encuentran:
Requisitos:
¿Qué necesitamos?
Competencias deseadas:
Información adicional:
Que ofrecemos:
Condiciones:
Vall d’Hebron Institute Oncology (VHIO) endorses the Requirements and Principles of the European Charter for Researchers, the Code of Conduct for the Recruitment of Researchers promoted by the European Commission and follows Equal Opportunities policies.
On 10th April 2018 VHIO was awarded the “HR Excellence in Research” logo. Our Institute was consequently granted permission to use the HR Excellence in Research Award logo as demonstration of its stimulating and favourable work environment in line with the Charter & Code.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO) has established itself as a cancer research center of proven excellence internationally. It is thanks to Josep's directorship and VHIO's optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d´Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d´Hebron University Hospital physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO's pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread and more effectively treating even the most undruggable tumour types.
VHIO's translation toward precision oncology.
